Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China-Reference-Cited by-同舟云学术

Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China

Published:2012-12-11 Issue:1 Volume:19 Page:27-34
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Tang L.¹,Wu R.¹,Sun J.²,Zhang X.³,Feng X.²,Zhang X.³,Luke K.-H.⁴,Poon M.-C.⁵

Affiliation:

1. Hemophilia Work Group; Beijing Children's Hospital affiliated to Capital Medical University; Beijing; China

2. Hemophilia Center; Nanfang Hospital affiliated to Nanfang Medical University; Guangzhou; China

3. Hemophilia Center of Shandong Province; Jinan; China

4. University of Ottawa; Children's Hospital of Eastern Ontario; Ottawa; ON; Canada

5. Foothills Hospital; University of Calgary; Calgary; AB; Canada

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2012.02926.x/fullpdf

Reference15 articles.

1. Secondary prophylaxis therapy: what are the benefits, limitations and unknowns?;Valentino;Haemophilia,2004

2. Treatment of children with haemophilia in Europe: a survey of 20 centers in 16 countries;Ljung;Haemophilia,2000

3. Optimizing factor prophylaxis for the haemophilia population: where do we stand;Blanchette;Haemophilia,2004

4. Haemophilia care in China: achievements of a decade of World Federation of Hemophilia (WFH) Treatment Center Twinning activities;Poon;Haemophilia,2008

5. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate hemophilia children: a pilot study in China;Wu;Haemophilia,2011

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India;Hematology;2023-11-07

2. Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature;Haemophilia;2022-10-12

3. The long‐term clinical benefits and economic costs associated with increased use of prophylaxis among patients with haemophilia A in China: Population‐based predictions from 2018 to 2033;Haemophilia;2022-06-17

4. Short-term intermittent prophylaxis post-intracranial hemorrhage in children with hemophilia;Paediatrica Indonesiana;2022-05-24

5. Inter-individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A;Thrombosis Research;2022-05